Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

Shelley Wood

March 24, 2023

News Features

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Shelley Wood

July 07, 2022

News Conference News THT 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Shelley Wood

February 02, 2022

News Industry News

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

February 02, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

Presentation TCT 2020

Temporary Spur Stent System for PVD Interventions (ReFlow)

Presenter: Jihad Mustapha

October 15, 2020

Presentation TCT 2020

Natural Vascular Scaffolding for PVD Interventions (Alucent)

Presenter: Myles Greenberg

October 15, 2020

News Daily News

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Michael O'Riordan

August 14, 2019

News Industry News

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

August 13, 2019

News Daily News

Same-Day Discharge After PCI Just as Safe as Overnight Stay, UK Study Finds

Marcus A. Banks

August 06, 2019

Presentation ISET 2019

The Economics of PVD: Current Costs and future Payment Models

Presenter: Gary Ansel

January 30, 2019

News Conference News VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

L.A. McKeown

September 15, 2017

Presentation TCT 2016

Complications of Coronary and Peripheral Vascular Intervention

Presenter: Sahil A. Parikh, Ehrin J. Armstrong

October 31, 2016

Presentation TCT 2015

Technical Overview of FDA-Approved and CE-Marked DCB Technologies for PVD Intervention

Presenter: Greg L. Kaluza, Thomas Zeller

October 12, 2015

Presentation TCT 2014

Status of DCB for PVD and Lessons Learned from the Recent FDA Panel

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Juan F. Granada

September 16, 2014

News Daily News

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Jason Kahn

January 01, 2014

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

Advertisement

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Temporary Spur Stent System for PVD Interventions (ReFlow)

Natural Vascular Scaffolding for PVD Interventions (Alucent)

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

Same-Day Discharge After PCI Just as Safe as Overnight Stay, UK Study Finds

The Economics of PVD: Current Costs and future Payment Models

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

Complications of Coronary and Peripheral Vascular Intervention

Technical Overview of FDA-Approved and CE-Marked DCB Technologies for PVD Intervention

Status of DCB for PVD and Lessons Learned from the Recent FDA Panel

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content